WellSpring Consumer Healthcare Acquires vH essentials from Wisconsin Pharmacal Company

Avista Capital Partners Acquires WellSpring Consumer Healthcare

August 23, 2022

Consumer Products

Avista Capital Partners completed the acquisition of WellSpring Consumer Healthcare from Audax Private Equity. WellSpring, founded in 1999 and headquartered in Sarasota, Florida, is a developer and marketer of over-the-counter and personal care brands (including Bactine, Bonine, Emetrol and Glaxal Base); Avista plans to support growth through product innovation, distribution expansion and strategic acquisitions.

WellSpring Consumer Healthcare Acquires A+D, Solarcaine and Other OTC Skin Care Brands from Bayer

April 4, 2023

Consumer Products

WellSpring Consumer Healthcare, a portfolio company of Avista Capital Partners, acquired a portfolio of OTC skin care brands from Bayer AG — including A+D, Solarcaine, Cortate and Complex 15 — to expand scale, product diversity and accelerate its innovation pipeline. Financial terms were not disclosed; the transaction is described as WellSpring's first add-on acquisition since Avista's investment in August 2022.

WellSpring Consumer Healthcare Acquires DerMend and Recticare from Ferndale Pharma Group

January 12, 2026

Consumer Products

WellSpring Consumer Healthcare, an Avista Healthcare Partners portfolio company, has acquired the DerMend and Recticare brands from Ferndale Pharma Group. The add-on expands WellSpring’s therapeutic skincare and OTC product portfolio and strengthens its omni-channel retail and e-commerce distribution; financial terms were not disclosed.

Cooper Consumer Health Acquires Viatris' Over-the-Counter Business

July 3, 2024

Pharmaceuticals

Cooper Consumer Health has completed the acquisition of the Over-the-Counter (OTC) business of Viatris Inc., following regulatory approvals and worker council consultations. The deal brings more than 200 brands (including Betadine, Saugella, Armolipid and CB12), two manufacturing sites in Mérignac (France) and Confienza (Italy) and an R&D centre in Monza (Italy) into Cooper's platform, doubling Cooper's revenues to approximately €1.2bn.

Avista Healthcare Partners Acquires Trillium Health Care Products

August 7, 2024

Pharmaceuticals

Avista Healthcare Partners has completed the acquisition of Trillium Health Care Products, a Brockville, Ontario-based CDMO specializing in branded over‑the‑counter (OTC) products, from New Water Capital. Avista plans to invest in Trillium’s growth, expand its footprint and capabilities, and use the business as a consumer‑healthcare platform for potential strategic add‑on acquisitions.

Avista Healthcare Partners Acquires PK Benelux

November 20, 2025

Consumer Products

Avista Healthcare Partners has completed its acquisition of PK Benelux, a leading Dutch vitamins, minerals and supplements (VMS) company and owner of the Lucovitaal brand. The deal strengthens Avista’s consumer health platform in Western Europe and will continue PK Benelux’s founder-led operations from its Uden headquarters.